MedTrace Logo

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures

NCT06220422 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 127

Last updated 2024-06-12

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that by allowing patients with an anticoagulant level less than 100 ng/ml to have their fracture managed surgically, will reduce the delay in surgery and therefore the complications associated. It will also demonstrate that there are no more complications with this new management than from remaining with a bleeding fracture.

Conditions

  • Femur Fracture

Interventions

PROCEDURE

Standard Department procedure for managing direct-acting oral anticoagulants

Standard Department procedure for managing direct-acting oral anticoagulants (NACO \< 50 ng/mL) in the management of fractures before September 2021

PROCEDURE

New Department procedure for managing direct-acting oral anticoagulants

New Department procedure for managing direct-acting oral anticoagulants (NACO \< 100 ng/mL) in the management of fractures after September 2021

Sponsors & Collaborators

  • Hôpital NOVO

    lead OTHER

Principal Investigators

  • Dr Amélie TOUSSAINT · Hôpital NOVO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-26
Primary Completion
2024-04-10
Completion
2024-04-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06220422 on ClinicalTrials.gov